Cited by 7Mitochondrial Function and PathologyNeuroscience and Neuropharmacology ResearchAutophagy in Disease and Therapy

Heterogeneous brain region-specific responses to astrocytic mitochondrial DNA damage in mice

Open access
Ayala, Daniela A., Matarazzo, Anthony, Seaberg, Bonnie L., Patel, Misha, Tijerina, Eliana, Matthews, Camryn, Bizi, Gabriel, Brown, Ashton +3 more·2024·Scientific Reports

Abstract

ABSTRACT Astrocytes use Ca 2+ signals to regulate multiple aspects of normal and pathological brain function. Astrocytes display context-specific diversity in their functions, and in their response to noxious stimuli between brain regions. Indeed, astrocytic mitochondria have emerged as key players in governing astrocytic functional heterogeneity, given their ability to dynamically adapt their morphology to regional demands on their ATP generation and Ca 2+ buffering functions. Although there is reciprocal regulation between mitochondrial dynamics and mitochondrial Ca 2+ signaling in astrocytes, the extent of this regulation into the rich diversity of astrocytes in different brain regions remains largely unexplored. Brain-wide, experimentally induced mitochondrial DNA (mtDNA) loss in astrocytes showed that mtDNA integrity is critical for proper astrocyte function, however, few insights into possible diverse responses to this noxious stimulus from astrocytes in different brain areas were reported in these experiments. To selectively damage mtDNA in astrocytes in a brain-region-specific manner, we developed a novel adeno-associated virus (AAV)-based tool, Mito-PstI, which expresses the restriction enzyme PstI, specifically in astrocytic mitochondria. Here, we applied Mito-PstI to two distinct brain regions, the dorsolateral striatum, and the hippocampal dentate gyrus, and we show that Mito-PstI can induce astrocytic mtDNA loss in vivo , but with remarkable brain-region-dependent differences on mitochondrial dynamics, spontaneous Ca 2+ fluxes and astrocytic as well as microglial reactivity. Thus, AAV-Mito-PstI is a novel tool to explore the relationship between astrocytic mitochondrial network dynamics and astrocytic mitochondrial Ca 2+ signaling in a brain-region-selective manner.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-024-69499-w

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mitochondria in central nervous system astrocytes are strategically distributed within subcellular regions in the astrocytic territory, endfeet and soma, and since astrocytes generally outnumber neurons in the CNS, astrocytic mitochondria are optimally positioned to cater to the high energy demands of CNS neurons, particularly substantia nigra pars compacta dopaminergic neurons.

    “Mitochondria in CNS astrocytes are strategically distributed within subcellular regions in the astrocytic territory, endfeet and soma”

    From Mitochondrial DNA Damage in Substantia Nigra Pars Compacta Astrocytes Exacerbates Dopaminergic Neuron Loss in a 6-Hydroxydopamine Mouse Model of Parkinsonism (2026) · cites this paper as Ayala et al. 2024

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • The morphology of astrocytic mitochondria in the SNc is distinct from the fusiform morphology previously reported in DLS astrocytes and resembles astrocytic mitochondria in the dentate gyrus of the hippocampus.

    “This distinct morphology is in stark contrast to the fusiform morphology of mitochondria previously reported by us in DLS astrocytes and resembles astrocytic mitochondria in the dentate gyrus of the hippocampus (Ayala et al. 2024; Huntington and Srinivasan 2021).”

    From Mitochondrial DNA Damage in Substantia Nigra Pars Compacta Astrocytes Exacerbates Dopaminergic Neuron Loss in a 6-Hydroxydopamine Mouse Model of Parkinsonism (2026) · cites this paper as Ayala et al. 2024

    The Results section reports that astrocytic mitochondria in the dentate gyrus are smaller and less abundant than those in the DLS, supporting a regional morphological contrast. The paper does not describe DLS mitochondria as fusiform or compare either region’s mitochondria with those in the SNc. Page numbers were not available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • The AAV Mito-PstI expresses PstI under control of the astrocyte-specific GfaABC1D promoter, is directed to the astrocytic mitochondrial matrix by a mito7 targeting signal, and cuts mitochondrial DNA at PstI recognition sites, thereby damaging mtDNA only in astrocytes within pre-specified Mito-PstI injected brain regions in vivo.

    “Our novel AAV called Mito-PstI, expresses the restriction enzyme PstI under control of the astrocyte-specific GfaABC1D promoter.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 30

  1. [1]Stogsdill, J. A., Harwell, C. C. & Goldman, S. A. Astrocytes as master modulators of neural networks: Synaptic functions and disease-associated dysfunction of astrocytes. Ann. N. Y. Acad. Sci. 1525, 41–60. 10.1111/nyas.15004 (2023). 37219367 10.1111/nyas.15004 · DOI
  2. [2]John Lin, C. C. et al. Identification of diverse astrocyte populations and their malignant analogs. Nat. Neurosci. 20, 396–405. 10.1038/nn.4493 (2017). 28166219 10.1038/nn.4493 PMC5824716 · DOI · Paper page
  3. [4]Khakh, B. S. & Deneen, B. The emerging nature of astrocyte diversity. Annu. Rev. Neurosci. 42, 187–207. 10.1146/annurev-neuro-070918-050443 (2019). 31283899 10.1146/annurev-neuro-070918-050443 · DOI
  4. [5]Zimmer, T. S., Orr, A. L. & Orr, A. G. Astrocytes in selective vulnerability to neurodegenerative disease. Trends Neurosci. 47, 289–302. 10.1016/j.tins.2024.02.008 (2024). 38521710 10.1016/j.tins.2024.02.008 PMC11006581 · DOI
  5. [6]Huntington, T. E. & Srinivasan, R. Astrocytic mitochondria in adult mouse brain slices show spontaneous calcium influx events with unique properties. Cell Calcium 10.1101/2020.06.21.163618 (2021). 33676316 10.1101/2020.06.21.163618 · DOI
  6. [7]Bazargani, N. & Attwell, D. Astrocyte calcium signaling: The third wave. Nat. Neurosci. 19, 182–189. 10.1038/nn.4201 (2016). 26814587 10.1038/nn.4201 · DOI
  7. [8]Jackson, J. G. & Robinson, M. B. Regulation of mitochondrial dynamics in astrocytes: Mechanisms, consequences, and unknowns. Glia 66, 1213–1234. 10.1002/glia.23252 (2018). 29098734 10.1002/glia.23252 PMC5904024 · DOI
  8. [9]Fecher, C. et al. Cell-type-specific profiling of brain mitochondria reveals functional and molecular diversity. Nat. Neurosci. 22, 1731–1742. 10.1038/s41593-019-0479-z (2019). 31501572 10.1038/s41593-019-0479-z · DOI
  9. [10]Stephen, T. L., Gupta-Agarwal, S. & Kittler, J. T. Mitochondrial dynamics in astrocytes. Biochem. Soc. Trans. 42, 1302–1310. 10.1042/BST20140195 (2014). 25233407 10.1042/BST20140195 · DOI
  10. [11]Bacman, S. R., Williams, S. L., Pinto, M. & Moraes, C. T. The use of mitochondria-targeted endonucleases to manipulate mtDNA. Methods Enzymol. 547, 373–397. 10.1016/B978-0-12-801415-8.00018-7 (2014). 25416366 10.1016/B978-0-12-801415-8.00018-7 PMC4274129 · DOI
  11. [12]Pickrell, A. M., Pinto, M., Hida, A. & Moraes, C. T. Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson’s disease. J. Neurosci. 31, 17649–17658. 10.1523/JNEUROSCI.4871-11.2011 (2011). 22131425 10.1523/JNEUROSCI.4871-11.2011 PMC3361134 · DOI
  12. [13]Fukui, H. & Moraes, C. T. Mechanisms of formation and accumulation of mitochondrial DNA deletions in aging neurons. Hum. Mol. Genet. 18, 1028–1036. 10.1093/hmg/ddn437 (2009). 19095717 10.1093/hmg/ddn437 PMC2722231 · DOI
  13. [14]Srivastava, S. & Moraes, C. T. Double-strand breaks of mouse muscle mtDNA promote large deletions similar to multiple mtDNA deletions in humans. Hum. Mol. Genet. 14, 893–902. 10.1093/hmg/ddi082 (2005). 15703189 10.1093/hmg/ddi082 PMC1242110 · DOI
  14. [15]Ignatenko, O. et al. Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy. Nat. Commun. 9, 70. 10.1038/s41467-017-01859-9 (2018). 29302033 10.1038/s41467-017-01859-9 PMC5754366 · DOI · Paper page
  15. [16]Lee, Y., Messing, A., Su, M. & Brenner, M. GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia 56, 481–493. 10.1002/glia.20622 (2008). 18240313 10.1002/glia.20622 · DOI
  16. [17]Venegas, V., Wang, J., Dimmock, D. & Wong, L. J. Real-time quantitative PCR analysis of mitochondrial DNA content. Curr. Protoc. Hum. Genet. 10.1002/0471142905.hg1907s68 (2011). 21234878 10.1002/0471142905.hg1907s68 · DOI
  17. [18]Harwig, M. C. et al. Methods for imaging mammalian mitochondrial morphology: A prospective on MitoGraph. Anal. Biochem. 552, 81–99. 10.1016/j.ab.2018.02.022 (2018). 29505779 10.1016/j.ab.2018.02.022 PMC6322684 · DOI
  18. [19]Helassa, N., Podor, B., Fine, A. & Török, K. Design and mechanistic insight into ultrafast calcium indicators for monitoring intracellular calcium dynamics. Sci. Rep. 6, 38276. 10.1038/srep38276 (2016). 27922063 10.1038/srep38276 PMC5138832 · DOI
  19. [20]Wang, Y. et al. Accurate quantification of astrocyte and neurotransmitter fluorescence dynamics for single-cell and population-level physiology. Nat. Neurosci. 22, 1936–1944. 10.1038/s41593-019-0492-2 (2019). 31570865 10.1038/s41593-019-0492-2 PMC6858541 · DOI · Paper page
  20. [22]Yang, Z. & Wang, K. K. Glial fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 38, 364–374. 10.1016/j.tins.2015.04.003 (2015). 25975510 10.1016/j.tins.2015.04.003 PMC4559283 · DOI · Paper page
  21. [23]Paolicelli, R. C. et al. Microglia states and nomenclature: A field at its crossroads. Neuron 110, 3458–3483. 10.1016/j.neuron.2022.10.020 (2022). 36327895 10.1016/j.neuron.2022.10.020 PMC9999291 · DOI · Paper page
  22. [24]Rong, Z. et al. The mitochondrial response to DNA damage. Front Cell Dev. Biol. 9, 669379. 10.3389/fcell.2021.669379 (2021). 34055802 10.3389/fcell.2021.669379 PMC8149749 · DOI
  23. [25]Kumari, S., Dhapola, R. & Reddy, D. H. Apoptosis in Alzheimer’s disease: Insight into the signaling pathways and therapeutic avenues. Apoptosis 28, 943–957. 10.1007/s10495-023-01848-y (2023). 37186274 10.1007/s10495-023-01848-y · DOI · Paper page
  24. [26]Witzig, V. S., Komnig, D. & Falkenburger, B. H. Changes in striatal medium spiny neuron morphology resulting from dopamine depletion are reversible. Cells 10.3390/cells9112441 (2020). 33182316 10.3390/cells9112441 PMC7695336 · DOI
  25. [27]Deutch, A. Y., Colbran, R. J. & Winder, D. J. Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism. Parkinsonism Relat. Disord. 13 (Suppl 3), S251-258. 10.1016/s1353-8020(08)70012-9 (2007). 18267246 10.1016/s1353-8020(08)70012-9 PMC4820336 · DOI
  26. [28]Youle, R. J. & van der Bliek, A. M. Mitochondrial fission, fusion, and stress. Science 337, 1062–1065. 10.1126/science.1219855 (2012). 22936770 10.1126/science.1219855 PMC4762028 · DOI · Paper page
  27. [29]Lee, S. & Min, K. T. The interface between ER and mitochondria: Molecular compositions and functions. Mol. Cells 41, 1000–1007. 10.14348/molcells.2018.0438 (2018). 30590907 10.14348/molcells.2018.0438 PMC6315321 · DOI
  28. [30]Gӧbel, J. et al. Mitochondria-endoplasmic reticulum contacts in reactive astrocytes promote vascular remodeling. Cell Metab. 31, 791-808.e798. 10.1016/j.cmet.2020.03.005 (2020). 32220306 10.1016/j.cmet.2020.03.005 PMC7139200 · DOI
  29. [31]West, A. P. et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520, 553–557. 10.1038/nature14156 (2015). 25642965 10.1038/nature14156 PMC4409480 · DOI · Paper page
  30. [32]De Gaetano, A. et al. Molecular mechanisms of mtDNA-mediated inflammation. Cells 10.3390/cells10112898 (2021). 34831121 10.3390/cells10112898 PMC8616383 · DOI

Cited by

Sorted by citations

Authors
Ayala, D. A., Matarazzo, A., Seaberg, B. L., Patel, M., Tijerina, E., Matthews, C., Bizi, G., Brown, A., Ta, A., Rimer, M., & Srinivasan, R.
Affiliations
Texas A&M University (US)
Corresponding author
  • Rimer, Mendell
  • Srinivasan, Rahul
Venue
Scientific Reports
Published
2024-08-10
Volume
14
Issue
1
Pages
18586-18586
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4401483195
Cited by
7
References
2
Citations by year
2026: 4 · 2025: 3
FWCI
0.91
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health (T32 GM135115)
  • National Institutes of Health,United States (T32 GM135748)
  • National Institute of Neurological Disorders and Stroke (R21 NS121959)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
Keywords
astrocytes, mitochondrial DNA damage, brain region specificity, mitochondrial dynamics, mitochondrial calcium signaling, dorsolateral striatum, dentate gyrus, microglial activation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review